Resources
About Us
Home Report
Store
Latin America PoC Diagnostics Market
Latin America PoC Diagnostics Market by Product (Blood glucose monitoring, Coagulation monitoring, Hematology testing, Cholesterol testing), Platform (Microfluidics, Molecular diagnostics), Mode (OTC Testing), End User- Forecast to 2027
Report ID:MRHC - 104410 Pages: 180 Jul-2020 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Latin American Point-of-Care (POC) Diagnostics Market is expected to grow at a CAGR of 16.1% from 2020 to 2027 to reach at $203 million by 2027. The Latin America region has noted significant epidemiological burden of infectious diseases like severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Ebola, chikungunya, avian flu, swine flu, Zika, and COVID-19 in the recent years. The increased prevalence of these diseases have led to a greater demand for PoC diagnostics technologies in the region. Furthermore, the growing geriatric population, increasing initiatives by manufacturers to widen their portfolio and enhance availability of advanced products in the Latin American region, shortage of skilled laboratory technicians, and increasing funding/investments for the development of PoC products are expected to propel the growth of the PoC diagnostics market in the region.
COVID-19 Impact on the Latin America PoC Diagnostics Market
Increase in prevalence of various chronic and infectious diseases such as cardiac diseases, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) play a vital role in the growth of the point of care diagnostics market. However, the recent outbreak of the coronavirus disease (COVID-19) has led to the rapid expansion of PoC diagnostics market in the region. In March 2020, Vale S.A., a Brazilian multinational corporation, purchased 5 million new coronavirus (COVID-19) rapid test kits to help the Brazilian government combat the spread of the illness in the country. Also, Hi Technologies, a Brazilian healthtech startup which specializes in laboratory exam equipment, is producing batches of rapid tests to diagnose COVID-19.
Amidst the ongoing pandemic, the overall adoption for point-of-care diagnostic test kits in the Latin American region has increased significantly, on the advice of WHO.
Click here to: Get Free Sample Pages of this Report
Growing prevalence of chronic and infectious diseases in the region
Currently, chronic infectious diseases caused by bacterial and viral pathogens are on the rise in Latin American countries due to various factors including changes in climatic conditions, increased human population growth and density in both urban and rural areas, increased human migration and mobility, and poor public health resources. The pathogenic agents that cause emerging and re-emerging diseases in Latin America include, bacterial pathogens (Salmonella enteritidis; Salmonella typhimurium, Salmonella typhi, Brucellaabortus and Klebsiella pneumonia) and viral pathogens (HPV; HIV; EBV; Zika and Chikungunya). According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), as in 2017, there were approximately 1.8 million people living with HIV in the Latin America region. According to Brazil’s Health Ministry, a total of 4,680 flu cases were found in Brazil in the first seven months of 2018. Also, according to the Global Cancer Institute, the prevalence of cancer in LATAM has increased in past decades and is further expected to rise by 35% by 2030. This is mainly attributed to the demographic and epidemiological transition in the region, changes in lifestyle and dietary patterns, and surge in risk factors. Further, the recent outbreak of coronavirus (COVID -19) is affecting large population in the region, which has led to sudden growth in demand for related POC diagnostic tests in the region.
Rising initiatives by key players in the region
Owing to the rapid increase in the geriatric population, chronic diseases are becoming a major health problem in Latin America. As a result, the demand for diagnostic products and services is increasing in the region. For instance, in 2019, Alere Inc. (U.S.) launched its ID NOW point of care molecular platform in Brazil with tests for the rapid detection of respiratory diseases, such as influenza, bronchiolitis, and pharyngotonsillitis.
Apart from such developments from point-of-care diagnostics tests providers, conferences and workshops to create awareness among local medical device manufacturers and healthcare community are also supporting the growth of the PoC testing market in Latin America.
Key findings of the Latin America PoC diagnostics market study:
Infectious diseases testing kits are expected to register the fastest growth during the forecast period
During 2018-2019, influenza caused 848 deaths in Mexico. Similarly, Brazil reported nearly 1,000 deaths from influenza in the first five months of 2016. These numbers are increasing every year. Rapid testing for influenza A and B allows for accurate and timely treatment, as patients only have a 48-hour window to receive critical antiviral therapy. Thus, the growing prevalence of infectious diseases and need for rapid testing and treatment provide robust revenue growth opportunities for players offering PoC tests in Latin America.
Based on mode, Over-The-Counter (OTC) testing kits segment to hold the largest share in 2020
The greater adoption of OTC over prescription kits is mainly due to the expansion of test portfolio from the POC technology providers, greater benefits offered by POC tests for patients and clinicians, enhanced quality of POC tests, and growing use of novel technologies such as nanotechnology and microfluidics in point of care testing products which enables the miniaturization of devices.
Home care/self-testing to hold the largest share of the PoC diagnostics market in 2020
Growing inclination towards at-home healthcare, increasing focus on continuous and remote patient monitoring, and increasing need for rapid tests among home care users support the high demand for point-of-care diagnostics products in home care/self-testing end user segment in the Latin America region.
Brazil to dominate the Latin America point of care diagnostics market in 2020
Brazil is estimated to command the largest share of the Latin America PoC diagnostics market in 2020. This market is expected to continue its dominance during the forecast period as well, driven by the rising prevalence of infectious diseases, diabetes, cancer and cardiac disorders; and increased healthcare spending in Brazil with its developing economy. Government initiatives to control the incidence levels of chronic and endemic diseases is also expected to support the growth of the point-of-care diagnostics market in Brazil during the forecast period.
Key Players
The report includes competitive landscape based on extensive assessment of the product portfolio, geographic presence, and key strategic developments adopted by leading market players in the industry over the past 4 years. The key players profiled in the Latin America PoC diagnostics market are Alere Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Quidel Corporation (U.S.), biomérieux S.A. (France), Chembio Diagnostics (U.S.), Johnson & Johnson (U.S.), Siemens Healthineers GmbH (Germany), and PTS Diagnostics (U.S.).
Scope of the Report:
Latin America PoC Diagnostics Market, by Product
- Blood Glucose Monitoring Testing Products
- Cardiac Metabolism Monitoring Testing Products
- Infectious Disease Testing Products
- Coagulation Monitoring Products
- Pregnancy and Fertility Testing Products
- Fecal Occult Testing Products
- Hematology Testing Products
- Tumor/Cancer Markers Testing Products
- Drugs of Abuse Testing Products
- Urinalysis Testing Products
- Cholesterol Testing Products
- Other PoC Testing Products
Latin America PoC Diagnostics Market, by Platform
- Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays)
- Dipsticks
- Microfluidics
- Molecular Diagnostics
Latin America PoC Diagnostics Market, by Mode
- Prescription-Based Testing Products
- Over-the-Counter (OTC) Testing Products
Latin America PoC Diagnostics Market, by End User
- Home Care/Self Testing
- Physician offices & Outpatient/Ambulatory Care Settings
- Hospitals
- Research Laboratories
Latin America PoC Diagnostics Market, by Geography
- Brazil
- Mexico
- Argentina
- Chile
- Colombia
- Peru
- Rest of LATAM
Areas of Focused Research Services in Latin America:
- Market Access
- In-depth Regulatory Analysis
- Assessment of Top Technology Trends
- End User Perception Analysis
- Partner Identification
- Due Diligence
- Distribution Channel Assessment
- Supply Chain Analysis
- Procurement Practices Analysis
- Key Customer Assessment
- Others
Key questions answered in the report:
The Latin America PoC diagnostics market projected to reach $203 million by 2027, at a CAGR of 16.1% during the forecast period.
Based on the product, the blood glucose monitoring testing segment is estimated to command the largest share of the Latin America PoC diagnostics market in 2020. However, the infectious disease diagnostics testing kits segment is expected to grow at the fastest CAGR during the forecast period.
Based on the product, the blood glucose monitoring testing segment is estimated to command the largest share of the Latin America PoC diagnostics market in 2020. However, the infectious disease diagnostics testing kits segment is expected to grow at the fastest CAGR during the forecast period.
Based on the mode of sale or prescription, the over-the-counter (OTC) testing kits segment is projected to create more traction during the forecast period owing to greater adoption of OTC over prescription kits and growing use of novel technologies such as nanotechnology and microfluidics, which enables the miniaturization of devices.
Increasing prevalence of infectious diseases along with the growing geriatric population, rising number of initiatives by manufacturers to widen their portfolio and enhance availability of advanced products, shortage of skilled laboratory technicians, and increasing funding/investments for the development of PoC products are driving the growth of Latin America PoC diagnostics market. Further, growing demand for home care therapeutic and diagnostic devices offer significant growth opportunities for the players operating in this market in the region.
The key players operating in the Latin America PoC Diagnostics market are Alere Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Quidel Corporation (U.S.), biomérieux S.A. (France), Chembio Diagnostics (U.S.), Johnson & Johnson (U.S.), Siemens Healthineers GmbH (Germany), Orangelife Comercio E Industria (Brazil), and PTS Diagnostics (U.S.) among others.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Increasing Prevalence of Infectious Diseases along with the Growing Geriatric Population
4.2.2. Increasing Initiatives by Manufacturers
4.2.3. Shortage of Skilled Laboratory Technicians
4.2.4. Increasing Funding/Investments for the Development of PoC Products
4.2.5. COVID -19 Impact Assessment
4.2. Restraints
4.2.1. Pricing Pressures Owing to Reimbursement Cuts and Budget Constraints
4.3. Opportunity
4.3.1. Growing Demand for Home Care Therapeutic Devices
4.4. Challenge
4.4.1. Lack of Knowledge about the Use of PoC Devices
5. Latin America PoC Diagnostics Market, by Product
5.1. Introduction
5.2.1. Strips
5.2.2. Meters
5.2.3. Lancets & Lancing Devices
5.3. Cardiac Metabolism Monitoring Testing Products
5.3.1. Blood Gas/Electrolytes Testing Products
5.3.2. Cardiac Markers
5.3.3. Hba1c Testing Products
5.4. Infectious Disease Testing Products
5.4.1. Influenza Testing Products
5.4.2. HIV Testing Products
5.4.3. Hepatitis C Testing Products
5.4.4. Sexually Transmitted Disease (STD) Testing Products
5.4.5. Healthcare Associated Infection (HAI) Testing Products
5.4.6. Respiratory Infection Testing Products
5.4.7. Tropical Disease Testing Products
5.4.8. Other Infectious Disease Testing Products
5.5. Coagulation Monitoring Products
5.5.1. Prothrombin Time (PT/INR) Testing Products
5.5.2. Activated Clotting Time (ACT/aPTT) Testing Products
5.6. Pregnancy and Fertility Testing Products
5.6.1. Pregnancy Testing Products
5.6.2. Fertility Testing Products
5.7. Fecal Occult Testing Products
5.8. Hematology Testing Products
5.9. Tumor/Cancer Markers Testing Products
5.10. Drugs of Abuse Testing Products
5.12. Cholesterol Testing Products
5.13. Other PoC Testing Products
6. Latin America PoC Diagnostics Market, By Platform
6.1. Introduction
6.2. Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays)
6.3. Dipsticks
6.4. Microfluidics
6.5. Molecular Diagnostics
7. Latin America PoC Diagnostics Market, by Mode
7.1. Introduction
7.2. Prescription-Based Testing Products
7.3. Over-the-Counter (OTC) Testing Products
8. Latin America PoC Diagnostics Market, by End User
8.1. Introduction
8.2. Home Care/Self Testing
8.3. Physician offices & Outpatient/Ambulatory Care Settings
8.4. Hospitals
8.5. Research Laboratories
9. Latin America PoC Diagnostics Market, by Country
9.1. Introduction
9.2. Brazil
9.3. Mexico
9.4. Argentina
9.5. Chile
9.6. Colombia
9.7. Peru
9.8. Rest of LATAM
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2019)
11. Company Profiles
11.1. Alere Inc.
11.1.1. Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. Strategic Developments
11.2. Quidel Corporation
11.2.1. Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.3. F. Hoffmann-La Roche Ltd
11.3.1. Business Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. Strategic Developments
11.4. Danaher Corporation
11.4.1. Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.5. Thermo Fisher Scientific
11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.5.4. Strategic Developments
11.6. bioMérieux S.A.
11.6.1. Business Overview
11.6.2. Financial Overview
11.6.3. Product Portfolio
11.6.4. Strategic Developments
11.7. Becton, Dickinson and Company
11.7.1. Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.7.4. Strategic Developments
11.8. Chembio Diagnostics
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. Johnson & Johnson
11.9.1. Business Overview
11.9.2. Financial Overview
11.9.3. Product Portfolio
11.9.4. Strategic Developments
11.10. Siemens Healthineers GmbH
11.10.1. Business Overview
11.10.2. Financial Overview
11.10.3. Product Portfolio
11.10.4. Strategic Developments
11.11. PTS Diagnostics
11.11.1. Business Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments
12. Appendix
12.1. Questionnaire
12.2. Available Customization
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
North America Molecular Diagnostics Market - Opportunity Analysis And Industry Forecast (2024-2030)
Published Date: Jul-2024
Latin America Livestock Diagnostics Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Latin America Telehealth Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Latin America NGS Market - Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Feb-2024
Latin America Molecular Diagnostics Market - Opportunity Analysis and Industry Forecasts (2024-2031)
Published Date: Jan-2024
